alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
U.S. flag
      An official website of the United States government, Department of Justice.
        Here's how you know
      Here's how you know**Official websites use .gov**
            
            A **.gov** website belongs to an official government organization in the United States.
      **Secure .gov websites use HTTPS**
            
            A **lock** (
            A locked padlock
            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. Menu

      
        close

            
            
                                              About
          Charter
          Legislation
          Members
          Meetings
          Reports & Resources

                            
                                About
          Contact Us
                  Share
FacebookXLinkedInRedditPinterestEmail Home
 Catherine E. Lhamon
Catherine E. Lhamon is the Assistant Secretary for Civil Rights at the U.S. Department of Education. Ms. Lhamon's 17-year track record of success has earned her repeat accolades as one of California's top women lawyers, and as a lawyer of the year for civil rights. She was also named one of California's Top 20 Lawyers under 40 in 2007. Immediately prior to coming to the Department of Education, Ms. Lhamon was the Director of Impact Litigation at Public Counsel, which is the nation's largest pro bono law firm. Before coming to Public Counsel, Ms. Lhamon practiced for a decade at the ACLU of Southern California, ultimately as Assistant Legal Director. Before then, Ms. Lhamon was a teaching fellow and supervising attorney in the Appellate Litigation Program at Georgetown University Law Center after clerking for The Honorable William A. Norris on the United States Court of Appeals for the Ninth Circuit. She received her J.D. from Yale Law School, where she was The Outstanding Woman Law Graduate, and graduated summa cum laude from Amherst College.
  
Date Created: July 10, 2020
 Top

      Coordinating Council on Juvenile Justice and Delinquency Prevention

        
        
                        Facebook
          
                      X
          
                      YouTube
  

      Secondary Footer link menu
            Accessibility
              Plain Language
              Privacy Policy
              Legal Policies and Disclaimer
              No FEAR Act
              Freedom of Information Act
              USA.gov
              Justice.gov
Exhibit 35.1

Servicer Compliance Statement of AmeriCredit Financial Services, Inc.

This Annual Statement as to Compliance is delivered to you pursuant to Section 2.9 (c) of the 2015-2 Servicing Supplement dated as of May 1,
2015 (the Agreement) and Item 1123 of Regulation AB, executed in connection with the formation of GM Financial Automobile Leasing Trust 2015-2 (the Trust), the issuance of the Notes by the Trust and the closing of the
transactions and the execution and delivery of the various documents by AmeriCredit Financial Services, Inc. (the Servicer) and GMF Leasing LLC in connection therewith. The capitalized terms used herein shall have the same meanings as in
the Agreement.

The undersigned certifies that I am the Executive Vice President, Corporate Controller and Chief Accounting Officer of the
Servicer. I further certify as follows:



| | 1. | I have conducted, or caused to be conducted under my supervision, a review of the Servicer during the preceding period from January 1, 2016 through December 31, 2016, and its performance under the Agreement.
| | -- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 2. | To the best of my knowledge, following such review, the Servicer has fulfilled all its obligations under the Agreement throughout such period, and, to the best of my knowledge, there has been no default in the
fulfillment of any such obligation.
| | -- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|                                     |  |                                         |  |                      
|------------------------------------ |  | --------------------------------------- |  | ---------------------
|AmeriCredit Financial Services, Inc. |  |                                        
|                                     |  |                                        
|By:                                  |  | /s/ Connie Coffey                       |  | Dated: March 15, 2017
|                                     |  | Connie Coffey                           |  |                      
|                                     |  | Executive Vice President, Corporate     |  |                      
|                                     |  | Controller and Chief Accounting Officer |  |
The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841*et seq.*) (BHC Act), Regulation Y (12 CFR Part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below.                 

The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The application also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Additional information on all bank holding companies may be obtained from the National Information website at www.ffiec.gov/​nic/​. 

Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than March 6, 2000. 

A. Federal Reserve Bank of Cleveland (Paul Kaboth, Banking Supervision) 1455 East Sixth Street, Cleveland, Ohio 44101-2566: 

1. Park National Corporation, Newark, Ohio; to acquire 100 percent of the voting shares of SNB Corp., Greenville, Ohio, and thereby indirectly acquire Second National Bank, Greenville, Ohio. 

2. Park National Corporation, Newark, Ohio; to acquire 100 percent of the voting shares of UB Bancshares, Inc., Greenville, Ohio, and thereby indirectly acquire United Bank, National Association, Greenville, Ohio.

Board of Governors of the Federal Reserve System, February 4, 2000. 

Robert deV. Frierson, 

Associate Secretary of the Board. 

[FR Doc. 00-3028 Filed 2-9-00; 8:45 am] 

BILLING CODE 6210-01-P
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Consumer Product Safety Division

# AGENCY:

U.S. Consumer Product Safety Commission, Washington, DC 20207.

# TIME AND DATE:

Wednesday, November 29, 2000.

# LOCATION:

Room 410, East-West Towers, 4330 East-West Highway, Bethesda, Maryland.

# STATUS:

Closed to the Public—Pursuant to 5 U.S.C. 552b(f) (1) and 16 CFR 1013.4(b) (3), (7), (9) and (10) and submitted to the Federal Register pursuant to 5 U.S.C. 552b(e)(3).

# MATTER TO BE CONSIDERED:

 

### Compliance Status Report

The staff will brief the Commission on the status of various compliance matters.

For a recorded message containing the latest agenda information, call (301) 504-0709.

# CONTACT PERSON FOR ADDITIONAL INFORMATION:

Sadye E. Dunn, Office of the Secretary, 4330 East West Highway, Bethesda, MD 20207 (301) 504-0800.

Dated: November 17, 2000.

Sadye E. Dunn,

Secretary.

[FR Doc. 00-29885 Filed 11-17-00; 2:09 pm]

BILLING CODE 6355-01-M
Case 3:22-cv-01415-S   Document 43   Filed 11/07/23    Page 1 of 1   PageID 419
```

[Congressional Bills 103th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1150 Introduced in House (IH)]

103d CONGRESS
  1st Session
                                H. R. 1150

 To amend the Controlled Substances Act and the Controlled Substances 
        Import and Export Act with respect to the drug fentanyl.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           February 25, 1993

 Mr. Rangel (for himself and Mr. Shays) introduced the following bill; 
which was referred jointly to the Committees on Energy and Commerce and 
                             the Judiciary

_______________________________________________________________________

                                 A BILL

 
 To amend the Controlled Substances Act and the Controlled Substances 
        Import and Export Act with respect to the drug fentanyl.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,
That--
            (1) section 401(b) of the Controlled Substances Act (21 
        U.S.C. 841(b)) is amended--
                    (A) in paragraph (1)(A)(vi)--
                            (i) by striking ``400 grams'' and inserting 
                        ``40 grams''; and
                            (ii) by striking ``or 100 grams'' and all 
                        that follows through the end of clause (vi) and 
                        inserting ``(fentanyl) or any of its 
                        analogues;''; and
                    (B) in paragraph (1)(B)(vi)--
                            (i) by striking ``40 grams'' and inserting 
                        ``4 grams''; and
                            (ii) by striking ``or 10 grams'' and all 
                        that follows through the end of clause (vi) and 
                        inserting ``(fentanyl) or any of its 
                        analogues;''; and
            (2) section 1010(b) of the Controlled Substances Import and 
        Export Act (21 U.S.C. 960(b)) is amended--
                    (A) in paragraph (1)(F)--
                            (i) by striking ``400 grams'' and inserting 
                        ``40 grams''; and
                            (ii) by striking ``or 100 grams'' and all 
                        that follows through the end of clause (vi) and 
                        inserting ``(fentanyl) or any of its 
                        analogues;''; and
                    (B) in paragraph (2)(F)--
                            (i) by striking ``40 grams'' and inserting 
                        ``4 grams''; and
                            (ii) by striking ``or 10 grams'' and all 
                        that follows through the end of clause (vi) and 
                        inserting ``(fentanyl) or any of its 
                        analogues;''.

                                 <all>
```
EXHIBIT 32.2

CERTIFICATE OF THE CHIEF FINANCIAL OFFICER
OF FNBH BANCORP, INC.

Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350):

I,
Janice B. Trouba,  Chief  Financial  Officer of FNBH  Bancorp,  Inc.,  certify,  to the
best of my knowledge and belief, pursuant to Section 906 of the Sarbanes-Oxley Act of
2002 (18 U.S.C. 1350) that:

(1)       
          The quarterly report on Form 10-Q for the quarterly period ended March 31, 2007,
          which this statement accompanies, fully complies with requirements of Section
          13(a) or 15(d) of the Securities Exchange Act of 1934 and;

(2)       
          The information contained in this quarterly report on Form 10-Q for the
          quarterly period ended March 31, 2007, fairly presents, in all material
          respects, the financial condition and results of operations of FNBH Bancorp,
          Inc.

|Date:  May 8, 2007 |  | FNBH BANCORP, INC.By /s/ Janice B. Trouba      
      Janice B. TroubaIts:  Chief Financial Officer
|------------------ |  | -----------------------------------------------------------------------------------------------------------------

The signed original of this written
statement required by Section 906, or other document authenticating, acknowledging, or
otherwise adopting the signature that appears in typed form within the electronic version
of this written statement required by Section 906, has been provided to FNBH Bancorp, Inc.
and will be retained by FNBH Bancorp, Inc. and furnished to the Securities and Exchange
Commission or its staff upon request
IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF TEXAS

AMARILLO DIVISION

DOUGLAS RAY RICHARDS, §

§

Plaintiff, §

§

v. § 2:22-CV-217-Z-BR

§

LORI K. REDMOND, §

§

Defendant. §

ORDER WITHDRAWING FINDINGS, CONCLUSIONS AND RECOMMENDATION

The Court is in receipt of a handwritten pleading submitted by Plaintiff in response to the 

undersigned’s Findings, Conclusions and Recommendation to Dismiss. (ECF 7). Therein, Plaintiff states 

he has been unable to comply with the Court’s previous orders due to ongoing medical treatment. (Id.). 

In order to provide Plaintiff a final opportunity to proceed with his case, the undersigned hereby 

WITHDRAWS the previously entered Findings, Conclusions and Recommendation to Dismiss. (ECF 6). 

Plaintiff is directed to submit a certified inmate trust fund account data sheet or pay the $402.00 

filing fee within 30 days from the date of this Order. 

IT IS SO ORDERED. 

ENTERED January 25, 2023.

Case 2:22-cv-00217-Z-BR Document 8 Filed 01/25/23 Page 1 of 1 PageID 23
<PAGE>

EXHIBIT  99.1

CERTIFICATION  PURSUANT  TO  18  U.S.C.  SECTION  1350,  AS  ADOPTED
PURSUANT  TO  SECTION  906  OF  THE  SARBANES-OXLEY  ACT  OF  2002

I,  David  Lieberman, the Chief Executive Officer and Chief Financial Officer of
Advanced  Plant  Pharmaceuticals,  Inc.  (the  "Company"),  certify, pursuant to
Section  906  of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to
the  best  of  my  knowledge:

(1)     the  Quarterly  Report  on  Form  10-QSB  of  the Company for the fiscal
quarter  ended June 30, 2002 (the "Report") fully complies with the requirements
of  Section  13  (a) or 15 (d) of the Securities Exchange Act of 1934 (15 U.S.C.
78m  or  78o(d));  and

(2)     the information contained in the Report fairly presents, in all material
respects,  the  financial  condition  and  results of operations of the Company.

Dated:  August  18,  2003


__________________________
David  Lieberman
Sole  Officer  and  Director




<PAGE>
Case 3:22-cr-00419-S Document 35 Filed 10/12/23 Page 1 of 1 PageID 95
ex10a.htm
















Exhibit (10)(a)

















Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm












We consent to the reference to our firm under the caption “Independent Registered Public Accounting Firm” in Post-Effective Amendment No. 52 to the 1933 Act Registration Statement (Form N-4 No. 033-27783) and Amendment No. 387 to the 1940 Act Registration Statement (Form N-4 No. 811-05721), and to the use therein of our reports dated (a) April 1, 2015, with respect to the consolidated financial statements of The Lincoln National Life Insurance Company and (b) April 8, 2015, with respect to the financial statements of Lincoln National Variable Annuity Account H for the interests in a separate account under individual flexible payment deferred variable annuity contracts.








/s/ Ernst & Young LLP









Philadelphia, Pennsylvania


October 1, 2015
#### The People of the State of New York, Respondent, v Patrick Michael Olivera, Appellant.

Judgment, Supreme Court, New York County (Joan B. Carey, J.), rendered August 18, 1986, convicting defendant, after jury trial, of felony murder and robbery in the first and second degrees, and sentencing him to concurrent terms of 15 years’ to life, 6 to 12 years’ and 5 to 15 years’ imprisonment, respectively, unanimously affirmed.

Defendant’s own admissible statements to the police, though filled with proven falsehoods, did place him at the scene of the crime. The sole issue was whether he had been a willing participant in a crime concededly committed by one or both of his companions. A defendant’s false statements to the police are considered a weak form of evidence only where otherwise unsupported by substantial proof *(People v Benzinger,*36 NY2d 29). The weight of evidence here amply supported the verdict.

Defendant offered no evidence at trial. In instructing the jurors on evaluating circumstantial evidence, the Trial Judge may have unintentionally marshaled certain elements of the People’s proof, while failing to balance this with inferences favorable to the defense. However, even if this instruction did constitute a "less than ideal” marshaling of evidence, our examination of the record reveals no prejudice because the informed efforts of competent counsel resulted in focusing the jury’s attention on the material issue of defendant’s participation in the crime *(People v Culhane,*45 NY2d 757, 758, *cert denied*439 US 1047). Concur—Murphy, P. J., Sullivan, Carro, Ellerin and Smith, JJ.
1 

### Werner, Christopher

From: Szabo, Aaron <Aaron_L_Szabo@omb.eop.gov> Sent: Monday, March 07, 2016 11:14 AM To: Lorang, Phil; Werner, Christopher; Beaver, Melinda Cc: Szabo, Aaron Subject: Summary of Additional Interagency Comments under EO 12866 and 13563: EPA NPRM -- Protection of Visibility: Amendments to Requirem ents for State Plans (RIN 2060- AS55) Attachments: Summary of Interagency Comments under EO12866_E0135 63_Regional Haze_ 2060....docx
Categories: Regional Haze

Attached please find the summary of additional inte ragency comments under EO 12866 and 13563 for the d raft proposed rule entitled, Protection of Visibility: Amendments to Requirement s for State Plans (RIN 2060-AS55), and in response to the most recent version provided to OMB for review.

Thank you and please let me know if you have any co mments or questions.

Aaron L. Szabo Policy Analyst Office of Information and Regulatory Affairs Office of Management and Budget 202-395-3621 Aaron_L_Szabo@omb.eop.gov
EXHIBIT 32.1


CERTIFICATION OF CHIEF EXECUTIVE OFFICER


PURSUANT TO
 18 U.S.C. SECTION 1350,
 AS ADOPTED PURSUANT TO
 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


I, Dovid Lieberman,  Chief  Executive  Officer  ofWorld Health Energy Holdings, Inc. (the "Company"),  hereby  certify,  pursuant to 18 U.S.C.  Section  1350,  as adopted pursuant  to  Section  906  of  the  Sarbanes-Oxley  Act of  2002,  that,  to my knowledge:
 
 (1) The  Company's  Quarterly  Report on Form 10-Q for the quarter  ended March 31, 2011, as filed with the Securities and Exchange  Commission on the date hereof (the  "Report"),  fully  complies with the  requirements  of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
 (2)  The  information  contained  in the  Report  fairly  presents,  in all material  respects,  the  financial  condition  and results of operations of the Company.
   /s/ Dovid Lieberman

Dovid Lieberman

Chief Executive Officer


Date: May 16, 2011








______________
 
 This  certification  accompanies  the  Report  pursuant  to  Section  906 of the Sarbanes-Oxley  Act of 2002 and  shall not be deemed  filed by the  Company  for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
 
 A signed  original of this written  statement  required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the  electronic  version of this written  statement required by Section 906,  has been  provided to the Company and will be retained by the Company and furnished to the  Securities  and Exchange  Commission or its staff upon request.
EXHIBIT 32.1

          Certification Pursuant to 18 U.S.C. Section 1350, As Adopted
            Pursuant to Section 906 of The Sarbanes-Oxley Act of 2002

I, David Lieberman, the Principal Executive Officer and Principal Financial
Officer of Advanced Plant Pharmaceuticals, Inc. (the "Company"), certify,
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section
1350, that to the best of my knowledge:

(1)      the Quarterly Report on Form 10-QSB of the Company for the fiscal
         quarter ended March 31, 2006 (the "Report") fully complies with the
         requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act
         of 1934 (15 U.S.C. 78m or 78o(d)); and

(2)      the information contained in the Report fairly presents, in all
         material respects, the financial condition and results of operations of
         the Company.


Date: June 21, 2006



/s/ David Lieberman
David Lieberman
Chief Executive Officer
Principal Financial Officer
Case 4:22-cv-00998-P Document 11 Filed 12/28/22 Page 1 of 9 PageID 51
Case 4:22-cv-00998-P Document 11 Filed 12/28/22 Page 2 of 9 PageID 52
Case 4:22-cv-00998-P Document 11 Filed 12/28/22 Page 3 of 9 PageID 53
Case 4:22-cv-00998-P Document 11 Filed 12/28/22 Page 4 of 9 PageID 54
Case 4:22-cv-00998-P Document 11 Filed 12/28/22 Page 5 of 9 PageID 55
Case 4:22-cv-00998-P Document 11 Filed 12/28/22 Page 6 of 9 PageID 56
Case 4:22-cv-00998-P Document 11 Filed 12/28/22 Page 7 of 9 PageID 57
Case 4:22-cv-00998-P Document 11 Filed 12/28/22 Page 8 of 9 PageID 58
Case 4:22-cv-00998-P Document 11 Filed 12/28/22 Page 9 of 9 PageID 59
IV 

111TH CONGRESS 

1ST SESSION H. CON. RES. 86 

Authorizing the use of Emancipation Hall in the Capitol Visitor Center 

for the unveiling of a bust of Sojourner Truth. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 30, 2009 

Ms. JACKSON-LEE of Texas submitted the following concurrent resolution; 

which was referred to the Committee on House Administration 

CONCURRENT RESOLUTION 

Authorizing the use of Emancipation Hall in the Capitol 

Visitor Center for the unveiling of a bust of Sojourner Truth. 

1 Resolved by the House of Representatives (the Senate 

2 concurring), 

3 SECTION 1. USE OF EMANCIPATION HALL FOR UNVEILING 

4 OF SOJOURNER TRUTH BUST. 

5 (a) AUTHORIZATION.—Emancipation Hall in the 

6 Capitol Visitor Center is authorized to be used for an 

7 event on April 28, 2009, to unveil a bust of Sojourner 

8 Truth. 

9 (b) PREPARATIONS.—Physical preparations for the 

10 conduct of the ceremony described in subsection (a) shall 


jbell on PROD1PC69 with BILLS
2 

•HCON 86 IH 

1 be carried out in accordance with such conditions as may 

2 be prescribed by the Architect of the Capitol. 

Æ 


jbell on PROD1PC69 with BILLS